Stock 300363 PORTON PHARMA SOLUTIONS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
16.63 CNY +1.59% Intraday chart for Porton Pharma Solutions Ltd. -0.48% -33.88%
Apr. 09 Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023. CI
Apr. 09 Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million. CI

Business Summary

Porton Pharma Solutions Ltd., formerly Porton Fine Chemicals Ltd., is a China-based company principally engaged in the provision of customized pharmaceutical research and production services. The Company is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The Company operates its businesses in Europe, North America, Asia and China, among others.

Number of employees: 5,263

Sales per Business

CNY in Million2021Weight2022Weight Delta
Post-clinical and Commercialization
89.3 %
2,039 65.7 % 6,282 89.3 % +208.17%
Early Clinical
8.7 %
973 31.3 % 613 8.7 % -36.96%
Others
2.0 %
94 3.0 % 139 2.0 % +48.65%

Sales per region

CNY in Million2021Weight2022Weight Delta
Foreign
89.9 %
2,426 78.1 % 6,322 89.9 % +160.59%
China
10.1 %
679 21.9 % 713 10.1 % +4.95%

Managers

Managers TitleAgeSince
Nian Feng Ju CEO
 Chief Executive Officer 52 10-12-31
Hui Chen DFI
 Director of Finance/CFO 45 22-04-21
Yong Qing Tan CHM
 Chairman 69 19-04-15
Hui Zeng BRD
 Director/Board Member 44 10-12-31
Xing Xing Wang IRC
 Investor Relations Contact 36 20-10-25
Wei Pi HRO
 Human Resources Officer 37 -
Po Zhu PRN
 Corporate Officer/Principal 54 10-12-29

Members of the board

Members of the board TitleAgeSince
Wei Gang Yuan BRD
 Director/Board Member 57 21-08-04
Nian Feng Ju CEO
 Chief Executive Officer 52 10-12-31
Hui Zeng BRD
 Director/Board Member 44 10-12-31
Guo Hua Cao BRD
 Director/Board Member 57 20-09-27
Lin Yuan BRD
 Director/Board Member 60 22-04-17
Yong Qing Tan CHM
 Chairman 69 19-04-15
Jin Wei Pang BRD
 Director/Board Member 56 22-04-17
Guo Jun Cao BRD
 Director/Board Member 59 22-04-17
Li Na Hu BRD
 Director/Board Member 65 22-04-17
Yu Chen Wu BRD
 Director/Board Member 32 22-04-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 554,113,964 310,763,341 ( 56.08 %) 8,076,144 ( 1.457 %) 56.08 %

Shareholders

NameEquities%Valuation
Chongqing Liangjiang New Area Industrial Development Group
15.80 %
78,982,719 15.80 % 196 M ¥
Rong Tao
8.848 %
44,218,630 8.848 % 110 M ¥
He Bing Zhang
8.385 %
41,903,020 8.385 % 104 M ¥
Zhong Ou Asset Management Co., Ltd
3.351 %
16,747,738 3.351 % 41 M ¥
Nian Feng Ju
2.946 %
14,722,630 2.946 % 36 M ¥
Hwabao WP Fund Management Co., Ltd.
1.697 %
8,482,060 1.697 % 21 M ¥
Zhangjiagang Zhuoyuan Investment Ptp LP
1.597 %
7,982,347 1.597 % 20 M ¥
China Merchants Fund Management Co., Ltd.
1.319 %
6,591,651 1.319 % 16 M ¥
GF Fund Management Co., Ltd.
1.286 %
6,427,677 1.286 % 16 M ¥
E Fund Management Co., Ltd.
0.8889 %
4,442,400 0.8889 % 11 M ¥
NameEquities%Valuation
Nian Feng Ju
95.44 %
44,167,891 95.44 % 109 M ¥

Company contact information

Porton Pharma Solutions Ltd.

7 Yuntu Road Beibei District

400714, Chongqing

+

http://www.porton.cn
address Porton Pharma Solutions Ltd.(300363)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Porton Pharma Solutions Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
16.63 CNY
Average target price
28.5 CNY
Spread / Average Target
+71.38%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PORTON PHARMA SOLUTIONS LTD. Stock Porton Pharma Solutions Ltd.
-33.88% 1.23B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.49% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.20% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-11.69% 149B
AMGEN INC. Stock Amgen Inc.
-6.43% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300363 Stock
  4. Company Porton Pharma Solutions Ltd.